Login to Pancreatic Cancer UK

Using PET scans to determine treatment response to preoperative radiotherapy and chemotherapy

Recipient: Dr Derek Grose

Host Institution: NHS Greater Glasgow and Clyde

Title: Using PET scans to determine treatment response to preoperative radiotherapy and chemotherapy

Type of award: 2015 Research Innovation Fund

Funding: £74,500 (funded by Pancreatic Cancer UK, Pancreatic Cancer Scotland and the Chief Scientist Office).

Dr Grose’s team are now proposing to use a new type of scan, called a PET scan, to identify areas of pancreatic cancer tumours that have low blood (and therefore oxygen) supply.

If they are able to use the scanner in this way, they may be able to predict which patients are likely to have the best response to preoperative chemotherapy and radiotherapy, and therefore ultimately the best outcome.

This is a promising area of investigation through which the researchers could develop a safe and effective tool that could be used in a clinical setting. This would enable doctors to decide the most appropriate treatment for pancreatic cancer patients maximising their chances of survival.